HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Dermatopathia pigmentosa reticularis

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Related Diseases

1.	Dyskeratosis Congenita (X-Linked Dyskeratosis Congenita)
2.	Hyperpigmentation
3.	Palmoplantar Keratoderma (Keratosis Palmaris et Plantaris)
4.	Ectodermal Dysplasia (Aplasia Cutis Congenita)
5.	Alopecia (Baldness)

Experts

1.	Al Saif, Fahad: 1 article (07/2016)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Dermatopathia pigmentosa reticularis:

1.	Keratin-14 (Keratin 14)IBA 07/01/2016 - "Dermatopathia pigmentosa reticularis (DPR) is a very rare autosomal dominant ectodermal dysplasia caused by mutations in keratin 14 and characterized by the triad of generalized reticulate hyperpigmentation, nonscarring alopecia, and onychodystrophy. "
2.	Etretinate FDA Link 09/01/1995 - "Palmoplantar keratoderma associated with dermatopathia pigmentosa reticularis: successful treatment with etretinate."
3.	Dichlorodiphenyldichloroethane (DDD)IBA 01/01/2023 - "Inherited RPDs include dyschromatosis symmetrica hereditaria (DSH), dyschromatosis universalis hereditaria (DUH), reticulate acropigmentation of Kitamura (RAK), Dowling-Degos disease (DDD), dyskeratosis congenita (DKC), Naegeli-Franceschetti-Jadassohn syndrome (NFJS), dermatopathia pigmentosa reticularis (DPR), and X-linked reticulate pigmentary disorder. "